期刊文献+

异补骨脂素对小鼠骨髓基质干细胞成骨和成脂分化影响及其机制的相关研究 被引量:4

Effects of isopsoralen on the osteogenic and adipogenic differentiation of bone marrow mesenchymal stem cells in mice
原文传递
导出
摘要 目的探索异补骨脂素对体外培养小鼠骨髓基质干细胞(BMSCs)成骨和成脂分化的影响及其作用机制。方法选取18只2个月大的无特定病原体级雌性C57/BL6小鼠,分离BMSCs。通过细胞培养、细胞增殖、碱性磷酸酶(ALP)染色实验、油红O染色实验建立并鉴定成骨、成脂细胞诱导,诱导14d后检测核心结合蛋白因子2(RUNX2)、骨钙素(OCN)、过氧化物酶体增殖物激活受体1(PPAR-γ)、CCAAT增强子结合蛋白β(C/EBP-β)确定浓度分别为0(对照组)、5、10、20μmol/L异补骨脂素的作用;并通过蛋白免疫印迹实验检测BMSCs成骨诱导及成脂诱导信号通路中P-S6(S235/236)、4E/BP1(Thr37/46)的表达。结果成骨诱导14d后10、20μmol/L组的BMSCs内ALP阳性表达量分别较对照组、5μmol/L组有增加,20μmol/L组ALP表达最强。5、10、20μmol/L组RUNX2、OCN的表达均较对照组增加,差异有统计学意义(P〈0.05),20μmol/L组RUNX2、OCN表达量最大。成脂诱导14d后5、10、20μmol/L的异补骨脂素浓度均能抑制BMSCs中PPAR-γ、C/EBP-β的表达,差异有统计学意义(P〈0.05),而20μmol/L的异补骨脂素抑制效果最强。成骨诱导14d后P—S6(S235/236)明显下降,且20μmol/L组最低,而4E/BP1(Thr37/46)的表达明显上升,对照组表达是最低。成脂诱导14d后P-S6(S235/236)表达明显上升,对照组P-S6(S235/236)表达最低,而4E/BP1(Thr37/46)的表达随异补骨脂素浓度的升高明显下降,且20p,mol/L组最低。结论异补骨脂素增强小鼠BMSCs成骨作用,抑制其向脂肪细胞分化,并证实异补骨脂素是通过抑制mTORC1信号通路活性抑制BMSCs向脂肪细胞分化。 Objective To explore the effects of isopsoralen on the osteogenic and adipogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) in mice and their mechanisms. Methods BMSCs were isolated from 18 2-month old female C57/BL6 mice that were specific pathogen free. Induced osteoblasts and fat cells were established and identified through cell culture, cell proliferation assay, alkaline phosphatase (ALP) staining and Oil Red O staining. After 14 days' induction, the core binding protein 2 (RUNX2), osteocalcin (OCN), a peroxisome proliferator activated receptor gamma (PPAR-γ) and CCAAT enhancer binding protein beta (C/EBP-β) were detected to determine the role of isopsoralen in groups of isopsoralen concentrations of 0, 5, 10 and 20 μmol/L. Western blotting was used to detect the expression of P-S6 (S235/236) and 4E/BP1 (Thr37/46) in the signal pathways for osteogenic induction and adipogenic induction of BMSCs. Results After osteogenic induction for 14 days: the positive expression of ALP in BMSCs in the 10 and 20 μmol/L groups were increased compared to the 0 and 5 μmol/L groups, with the highest in the 20 μmol/L group; the expression of RUNX2 and OCN in the 5, 10 and 20 μmol/L groups was significantly increased compared to the 0 μmol/L group, with the highest in the 20μmol/L group (P 〈 0. 05) . After adipogenic induction for 14 days: the isopsoralen in the 5, 10 and 20 μmol/L groups significantly inhibited the expression of PPAR-γ and C/EBP-B in BMSCs, with the most in the 20 μmol/L group ( P 〈0. 05) . After osteogenic induction for 14 days: the expression of P-S6 (S235/236) was obviously decreased, with the lowest in the 20 μmol/L group; the expression of 4E/BP1 (Thr37/46) was obviously increased, with the lowest in the 0μmol/L group. After adipogenie induction for 14 days: the expression of P-S6 (S235/236) was obviously increased, with the lowest in the 0 μmol/L group; the expression of 4E/ BP1(Thr37/46) was obviously decreased, with the lowest in the 20 μmol/L group. Conclusions Isopsoralen may enhance osteogenesis of BMSCs and inhibit BMSCs from differentiation into fat cells. The present experiment has also confirmed that isopsoialen inhibits the adipogenic differentiation of BMSCs by inhibiting the activity of mTORC 1 signaling pathway.
出处 《中华创伤骨科杂志》 CAS CSCD 北大核心 2015年第12期1078-1085,共8页 Chinese Journal of Orthopaedic Trauma
基金 国家自然科学基金(81560368) 内蒙古自治区人民医院院内基金(201428)
关键词 骨髓细胞 成骨细胞 成脂分化 异补骨脂素 成骨分化 Bone marrow ceils Osteoblasts Adipogenesis Isopsoralen Osteogenic
  • 相关文献

参考文献28

  • 1Gordon GS, Vaugban C. Postmenopausal osteoporosis[J]. Prim Care, 1974, 1(4): 565-582.
  • 2Wang ZQ, Li JL, Sun YL, et al. Chinese herbal medicine for osteo- porosis: a systematic review of randomized controlled trails[J]. Evid Based Complement Altemat Med, 2013, 2013: 356260.
  • 3王建华,郭敏,郑丽,王忠.补骨脂素干预大鼠成骨细胞骨保护素/核因子κB受体激活因子配体mRNA的表达[J].中国组织工程研究与临床康复,2010,14(37):6927-6930. 被引量:49
  • 4明磊国,陈克明,葛宝丰,马慧萍,翟远坤.异补骨脂素对体外培养大鼠成骨细胞增殖分化成熟的影响[J].中药材,2011,34(3):404-408. 被引量:21
  • 5Nuttall ME, Gimble JM. Is there a therapeutic opportunity to either prevent or treat osteopenic disorde~ by inhibiting marrow adipogene- sis?[J]. Bone, 2000, 27(2): 177-184.
  • 6Burkhardt R, Kettner G, Bohm W, et al. Changes in trabocular bone, hematopeiesis and bone marrow vessels in aplastic anemia, primary esteoperosis, and old age: a comparative histomorpbometric study[J].Bone, 1987, 8(3): 157-164.
  • 7Griffith ,IF, Yeung DK, Antonio GE, et al. Vertebral marrow fat content and diffusion and perfusinn indexes in women with varying bone density: MR evaluation[J] . Radiology, 2006, 241(3): 831-838.
  • 8Majors AK, Boehm CA, Nitto H, et al. Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation [J]. J Orthop Res, 1997, 15(4): 546-557.
  • 9Song L, Tuan RS. Transdifferentiation potential of human mesenchy- real stem cells derived from bone marrow[J~ . FASEB J, 2004, 18 (9): 980-982.
  • 10Park SR, Oreffo RO, Triffitt JT. Intereonversion potential of cloned human marrow adipocytes in vitro[J] Bone, 1999, 24(6): 549-554.

二级参考文献25

  • 1林举择,陈升恺,罗家栋.补骨脂注射液对体外培养大鼠成骨细胞增殖的影响[J].中医正骨,2004,16(6):6-7. 被引量:62
  • 2中华人民共和国科学技术部.关于善待实验动物的指导性意见.2006.09-30
  • 3Takahashi N,Udagawa N,Suda T.A new member of tumor necrosis factor ligand family,ODF/OPGL/TRANCE/RANKL,regulates osteoclast differentiation and function.Biochem Biophys Res Commun.1999;256(3):449-455.
  • 4Hofbauer LC,Khosla S,Dunstan CR,et al.The roles of osteoprotegerin and osteoprotegedn ligand in the paracrine regulation of bone resorption.J Bone Miner Res.2000;15(1):2-12.
  • 5Atmaca A,Kleerekoper M,Bayraktar M,et al.Soy isoflavones in the management of postmenopausal osteoporosis.Menopause.2008;15(4 Pt 1):748-757.
  • 6Vatanparast H,Chilibeck PD.Does the effect of soy phytoestrogens on bone in postmenopausal women depend on the equol-producing phenotype? Nutr Rev.2007;65(6 Pt 1):294-299.
  • 7Cassidy A,Albertazzi P,Lise Nielsen I,et al.Cdtical review of health effects of soyabean phyto-oestrogens in post-menopausal women.Proc Nutr Soc.2006;65(1):76-92.
  • 8Coxam V.Phyto-oestrogens and bone health.Proc Nutr Soc.2008;67(2):184-195.
  • 9Coxam V.Prevention of osteopaenia by phyto-oestrogens:animal studies.Br J Nutr.2003;89 Suppl 1:S75-85.
  • 10Bingham SA,Atkinson C,Liggins J,et al.Phyto-oestrogens:where are we now? Br J Nutr.1998;79(5):393-406.

共引文献81

同被引文献58

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部